10 XP 0   0   5  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Amicus Therapeutics Inc - Trending symbols

Latest News of Amicus Therapeutics Inc

DateTitleRead
2025-04-07
14:30
AMICUS STOCKHOLDER ALERT: Kaskela Law LLC Announces Investigation of Amicus Therapeutics, Inc. (NASDAQ: FOLD) and Encourages Long-Term Investors to Contact the FirmRead
2025-03-21
16:30
Amicus Therapeutics (FOLD) Up 0.1% Since Last Earnings Report: Can It Continue?Read
2025-03-21
15:10
Why This 1 Momentum Stock Could Be a Great Addition to Your PortfolioRead

Notifications

TypeNotificationDate
RSI OversoldOversold RSI (Relative Strength Index)2025-04-17



Trends

 2023-12-312024-03-312024-06-302024-09-302024-12-31
Tax Provision 2,1832,6534,83610,96915,805-2,29113,514-20,319-6,805
Income Tax Expense 2,1832,6534,83610,96915,805-2,29113,514-20,319-6,805
Net Income -33,843-14,576-48,41932,722-15,6978,968-6,72921,46814,739
Net Income from Continuing Operations -33,843-14,576-48,41932,722-15,6978,968-6,72921,46814,739
Income before Tax -40,51715,812-24,705-6,955-31,660-11,923-43,58343,691108
EBIT -26,554-4,881-31,43527,743-3,692-17,984-21,67636,64314,967
EBITDA -24,348-4,859-29,20727,697-1,510-18,012-19,52236,67117,149
Operating Income -18,8601,837-17,02313,331-3,692-17,984-21,67636,64314,967
Interest Expense 9,6201,47511,09574911,84464812,492-25,478-12,986
Accumulated Other Comprehensive Income -17,240-21,838-39,07826,973-12,1055,361-6,74410,9044,160
Net non Operating Income Other 142,0212,0355,5897,6246,57314,197-30,853-16,656
Depreciation and Amortization 1,5181,9283,4465,5128,9586,52515,483-30,828-15,345
Total Other Income Expense Net -8,077-73-8,1502,038-6,1125,479-6335,2104,577
Net Tangible Assets 16,113139,719155,832-69,26086,572-68,75217,820-42,192-24,372

Comments

How you think about this?

Leave a comment

Stay informed about Amicus Therapeutics Inc.

Receive notifications about Amicus Therapeutics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.